Klarbakt (Clarbact) of its pharmacological characteristics belongs to the category of drugs antibacterial, bacteriostatic and bactericidal action. It belongs to the pharmacotherapeutic group of antibiotics, macrolide and azalide is antiinfectives for systemic use.
In the international classification system is called Clarithromycin.
Structure and Composition
Klarbakt produced in the form of tablets, coated tablets and containing 250 or 500 mg of active substance - clarithromycin.
As auxiliary substances Klarbakt includes:
- microcrystalline cellulose;
- corn starch;
- pregelatinized starch;
- purified talc;
- sodium starch glycolate;
- colloidal silicon dioxide;
- stearic acid;
- magnesium stearate.
The package can be 4 or 10 tablets.
According to the instructions, Klarbakt indicated for the treatment of bacterial infections of the nature, caused by susceptible organisms, including:
- infections that occurred in the upper respiratory tract (laryngitis, pharyngitis, tonsillitis, sinusitis, etc.);
- infections that occurred in the lower respiratory tract (acute and chronic bronchitis, pneumonia, SARS);
- infections of skin and soft tissue (folliculitis, abrasions, wound infection, impetigo, streptoderma, etc.);
- gastric ulcer and 12 duodenal ulcer (appointed as part of combination therapy);
- otitis media;
The drug is not prescribed Klarbakt:
- if the individual sensitivity to antibiotics, macrolides, the active ingredient of the drug (clarithromycin), erythromycin;
- in case of serious violations of the liver;
- in renal failure;
- when porphyria;
- during pregnancy and breastfeeding.
Prohibited use in combination therapy Klarbakta, which already includes macrolide drugs.
Instructions Klarbakta: Dosage and Administration
Tablets Klarbakt taken orally without chewing. Washed down with a small amount of liquid.
Klarbakta daily dose for adults and children from 12 years of age is 500 mg. Taken twice a day at 250 mg.
In the case of serious illness can be assigned a double dose - 1000 mg / day. It is taken twice a day at 500 mg.
In extreme cases, the maximum daily dose can be raised to 2 g / day, but it should not exceed it.
Like most of his peers, Klarbakt take depending on the complexity of the disease from 6 days to 2 weeks.
Treatment of AIDS patients, according to studies and reviews of Klarbakte, it is appropriate to continue to improve their overall clinical and microbiological status.
In each case the decision on the duration of treatment and dosage of the drug Klarbaktom should take doctor.
Klarbakta analogues are the following drugs:
- Arvitsin retard;
- Fromilid Uno;
- Klabaks other.
Possible side effects of Klarbakta
According to reviews, Klarbakt can cause a number of side unpleasant symptoms.
On the part of the central nervous system and sensory organs are: dizziness, increased anxiety, insomnia, headaches, nightmares, tinnitus, taste disturbance. Less common symptoms can be observed disorientation, psychosis and hallucinations, depersonalization, confused in the mind. In rare cases, possible loss of hearing, and paresthesia (recovering from drug withdrawal).
Possible violations of the gastrointestinal tract, manifesting disorders, nausea, vomiting, cholestatic jaundice, enterocolitis. Rarely can develop hepatitis and liver failure.
In rare cases, possible malfunctions of the cardiovascular and circulatory systems: arrhythmia, bleeding and bleeding unusual nature, ventricular fibrillation, etc.
In rare cases of dysfunction of the genitourinary system.
There may be allergic reactions in the form of itching and rashes on the skin.
It may develop hypoglycemia (rare).
Klarbakt stored at a temperature not exceeding 20 ° C. The product is usable for two years.